ADVANCED MIC.DEV. DL-,01/ US0079031078 /
2024-11-12 9:56:25 PM | Chg. -3.200 | Volume | Bid9:56:25 PM | Ask9:56:25 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
134.980EUR | -2.32% | - Turnover: - |
134.980Bid Size: - | 135.140Ask Size: - | 218.31 bill.EUR | - | - |
GlobeNewswire
09-01
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
08-27
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
08-27
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
08-26
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
08-23
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...